Disease transmission Archives - Revista Brasileira de Ginecologia e Obstetrícia
Summary
Revista Brasileira de Ginecologia e Obstetrícia. 2006;28(8):467-472
DOI 10.1590/S0100-72032006000800005
PURPOSE: to assess human T-cell lymphotropic virus type I (HTLV-I) seroprevalence among pregnant women attended at Public Health Units in Goiânia-Goiás and some epidemiologic characteristics of the studied group. METHODS: from September/2003 to December/2004, 15,485 pregnant women were submitted to enzyme-linked immunoabsorbent assays (ELISA), to screen HTLV-I, using filter paper - dried blood in, and to confirm the infection, polymerase chain reaction (PCR) of whole blood was performed. The epidemiologic factors evaluated were: average age, age of 30 years and above, schooling less than nine years, marital status and number of pregnancies. The factors average age, age of 30 years and above, and schooling less than nine years were compared between the infected and non-infected pregnant group. Statistical analysis used Fisher's exact test and Student's t test. RESULTS: the found prevalence was 0.1%. The average age among the infected pregnant group was 26.4 years, 43.7% of them being 30 years old and above, and 62.5% with schooling less than nine years. The non-infected group showed an average age of 24.4 years, 15.4% of them being ³ 30 years old and above, and only 41.5% with schooling less than nine years. Significant statistical difference was noticed only regarding age of 30 years and above and schooling less than nine years. CONCLUSION: the study shows that HTLV-I seroprevalence among pregnant women in Goiânia during the studied period was 0.1%. It occurred more among pregnant women who were 30 years old and above and those with schooling of less than nine years.
Summary
Revista Brasileira de Ginecologia e Obstetrícia. 2006;28(8):467-472
DOI 10.1590/S0100-72032006000800005
PURPOSE: to assess human T-cell lymphotropic virus type I (HTLV-I) seroprevalence among pregnant women attended at Public Health Units in Goiânia-Goiás and some epidemiologic characteristics of the studied group. METHODS: from September/2003 to December/2004, 15,485 pregnant women were submitted to enzyme-linked immunoabsorbent assays (ELISA), to screen HTLV-I, using filter paper - dried blood in, and to confirm the infection, polymerase chain reaction (PCR) of whole blood was performed. The epidemiologic factors evaluated were: average age, age of 30 years and above, schooling less than nine years, marital status and number of pregnancies. The factors average age, age of 30 years and above, and schooling less than nine years were compared between the infected and non-infected pregnant group. Statistical analysis used Fisher's exact test and Student's t test. RESULTS: the found prevalence was 0.1%. The average age among the infected pregnant group was 26.4 years, 43.7% of them being 30 years old and above, and 62.5% with schooling less than nine years. The non-infected group showed an average age of 24.4 years, 15.4% of them being ³ 30 years old and above, and only 41.5% with schooling less than nine years. Significant statistical difference was noticed only regarding age of 30 years and above and schooling less than nine years. CONCLUSION: the study shows that HTLV-I seroprevalence among pregnant women in Goiânia during the studied period was 0.1%. It occurred more among pregnant women who were 30 years old and above and those with schooling of less than nine years.
Summary
Revista Brasileira de Ginecologia e Obstetrícia. 2005;27(12):768-778
DOI 10.1590/S0100-72032005001200010
Knowledge about the factors or situations that influence the vertical transmission (VT) of human immunodeficiency type 1 (HIV-1) has led to the implementation of strategies which have promoted a rate decline along the years, from 40% to less than 3% nowadays. One of the major advances in the area has been the prophylactic administration of zidovudine (AZT), in the prenatal phase (oral route), in the predelivery phase (intravenous route) and to the newborn (oral route). This intervention may reduce HIV-1 VT 68%, thus being the most effective isolated strategy used so far. In the chronological sequence of advances, it has been observed that a high viral load is the main risk indicator for this type of transmission. As AZT does not reduce the viral load and does not control the residual rate observed in HIV-1 VT, the use of prophylactic schemes using three antiretroviral drugs has been encouraged. Elective caesarean section completes the range of obstetric strategies with major impact on the reduction of HIV-1 VT. Its effectiveness is linked to the observation of the criteria for its indication: viral load assessed after the 34th week of pregnancy with levels over 1000 copies/mL, gestation over 38 weeks confirmed by ultrasonography, intact chorioamniotic membranes, and performed before labor has started. In cases where normal delivery is indicated, it should be remembered that prolonged chorioamniorrhexis, invasive manipulation of the fetus, delivery with instruments and episiotomy are situations to be avoided. Among the postnatal interventions considered important for the reduction of HIV-1 VT are: pediatric reception (this should be done by trained professionals, avoiding microtraumas in the mucosa during the sucking maneuvers, use of neonatal AZT (for a period of six weeks) and bottle feeding. Special attention should be given to the orientation for the mother, in order to prevent acute infection by HIV-1 in this period, what would markedly increase virus VT rate.
Summary
Revista Brasileira de Ginecologia e Obstetrícia. 2005;27(12):768-778
DOI 10.1590/S0100-72032005001200010
Knowledge about the factors or situations that influence the vertical transmission (VT) of human immunodeficiency type 1 (HIV-1) has led to the implementation of strategies which have promoted a rate decline along the years, from 40% to less than 3% nowadays. One of the major advances in the area has been the prophylactic administration of zidovudine (AZT), in the prenatal phase (oral route), in the predelivery phase (intravenous route) and to the newborn (oral route). This intervention may reduce HIV-1 VT 68%, thus being the most effective isolated strategy used so far. In the chronological sequence of advances, it has been observed that a high viral load is the main risk indicator for this type of transmission. As AZT does not reduce the viral load and does not control the residual rate observed in HIV-1 VT, the use of prophylactic schemes using three antiretroviral drugs has been encouraged. Elective caesarean section completes the range of obstetric strategies with major impact on the reduction of HIV-1 VT. Its effectiveness is linked to the observation of the criteria for its indication: viral load assessed after the 34th week of pregnancy with levels over 1000 copies/mL, gestation over 38 weeks confirmed by ultrasonography, intact chorioamniotic membranes, and performed before labor has started. In cases where normal delivery is indicated, it should be remembered that prolonged chorioamniorrhexis, invasive manipulation of the fetus, delivery with instruments and episiotomy are situations to be avoided. Among the postnatal interventions considered important for the reduction of HIV-1 VT are: pediatric reception (this should be done by trained professionals, avoiding microtraumas in the mucosa during the sucking maneuvers, use of neonatal AZT (for a period of six weeks) and bottle feeding. Special attention should be given to the orientation for the mother, in order to prevent acute infection by HIV-1 in this period, what would markedly increase virus VT rate.
